G: One Health Microbiome Partnerships
Our Active Working Groups
WMP members participate through Working Groups tasked with specific objectives, reporting their progress to the Executive Committee and the broader membership.
G: One Health Microbiome Partnerships

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
F: Environmental Microbiomes and Climate Change

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
E: FAIR Microbiome Data

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
A: Human Microbiome and Public Health Targets

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
B: Microbiome Technologies

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
C: Microbiome Product Development and Regulatory Science

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
D: Agrifood System Microbiomes

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
VIB-KU, Leuven
VIB-KU, Leuven
VIB-KU, Leuven
Microbiome Technologies
Establishing microbiome-based targets for public health interventions and policy development.

VIB-KU, Leuven

APHP

Seres Therapeutics

Seres Therapeutics
- Development of standardized protocols for microbiome monitoring in public health.
- Creation of a roadmap for integrating microbiome data into epidemiological studies.
- Definition of key biomarkers for population-level health assessments.
